The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R-5135) 3-Hydroxy-16-imino-10,13-dimethyl-11-oxo-hexadecahydro-17-azonia-cyclopenta[a]phenanthrene ID: ALA1161036
PubChem CID: 44353719
Max Phase: Preclinical
Molecular Formula: C18H28N2O2
Molecular Weight: 304.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: R-5135 | R-5135|CHEMBL1161036
Canonical SMILES: C[C@]12CC(=O)C3C(CC[C@@H]4C[C@H](O)CC[C@]34C)C1CC(=N)N2
Standard InChI: InChI=1S/C18H28N2O2/c1-17-6-5-11(21)7-10(17)3-4-12-13-8-15(19)20-18(13,2)9-14(22)16(12)17/h10-13,16,21H,3-9H2,1-2H3,(H2,19,20)/t10-,11-,12?,13?,16?,17+,18+/m1/s1
Standard InChI Key: LLAKESJIQFAQJA-AORADPIQSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
1.9750 -1.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5500 -0.9292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9250 -1.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4042 -2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4417 -2.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9250 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9667 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4542 -0.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8917 -1.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4042 -2.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4375 -2.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1208 -1.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5375 -1.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4917 -1.4250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4042 -0.7917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9167 -2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1208 -2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9667 -0.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6333 -2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6333 -2.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4000 -1.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1500 -2.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4000 -3.1917 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 6 1 0
4 3 1 0
5 7 1 0
6 8 1 0
7 1 1 0
8 1 1 0
9 2 1 0
10 4 1 0
11 5 1 0
12 4 1 0
13 7 1 0
14 9 2 0
15 6 2 0
16 11 1 0
17 10 1 0
1 18 1 1
19 12 1 0
20 19 1 0
4 21 1 1
20 22 1 6
10 23 1 1
13 9 1 0
3 5 1 0
10 16 1 0
17 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.43Molecular Weight (Monoisotopic): 304.2151AlogP: 2.50#Rotatable Bonds: ┄Polar Surface Area: 73.18Molecular Species: BASEHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.79CX LogP: 1.25CX LogD: -1.16Aromatic Rings: ┄Heavy Atoms: 22QED Weighted: 0.64Np Likeness Score: 2.04
References 1. Melikian A, Schlewer G, Chambon JP, Wermuth CG.. (1992) Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists., 35 (22): [PMID:1331456 ] [10.1021/jm00100a015 ]